Can GW Pharma (GWPH) Continue to Rise? - Tale of the Tape


Shutterstock photo

Investors have definitely seen some solid trading in GW Pharmaceuticals PLC ( GWPH ) lately, leading to gains for some. However, GWPH is now in overbought territory thanks to its latest move, as the firm has an RSI value of 71.3. Additionally, GW Pharma currently has a Zacks Rank #4 (Sell), so if the earnings estimate trend is any guide, a fall might be coming for this overbought stock.

GW PHARMA-ADR (GWPH): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks

More from


Equity Research
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by